Li, Xue
Pathadka, Swathi
Man, Kenneth K. C.
Ng, Vanessa W. S.
Siu, Chung Wah
Wong, Ian C. K.
Chan, Esther W.
Lau, Wallis C. Y. http://orcid.org/0000-0003-2320-0470
Funding for this research was provided by:
University of Hong Kong-University College London (HKU-UCL) Strategic Partnership Fund
Pfizer Corporation Hong Kong Limited
Article History
First Online: 18 June 2020
Compliance with Ethical Standards
:
: This work was supported by the University of Hong Kong-University College London (HKU-UCL) Strategic Partnership Fund and an unconditional education grant from Pfizer Corporation Hong Kong Limited. The funders had no role in the study design, data collection and analysis, preparation of the manuscript, or decision to publish.
: The datasets generated during and/or analysed during the current study are not publicly available because of the nature of sensitive electronic medical data. Code will be available upon request from the corresponding author.
: EW Chan has received honoraria from the HA and research funding from The Hong Kong Research Grants Council; The Research Fund Secretariat of the Food and Health Bureau; the Narcotics Division of the Security Bureau of HKSAR, Hong Kong; the National Natural Science Fund of China, China; the Wellcome Trust, UK; Bayer; Bristol Myers Squibb; Pfizer, and Takeda for work unrelated to this study. ICK Wong has received research funding outside the submitted work from Bristol Myers Squibb, Janssen, Bayer, Novartis, GSK, the Hong Kong Research Grants Council, and the Hong Kong Health and Medical Research Fund. X Li has received research grants from the Hong Kong Health and Medical Research Fund and Janssen and internal seed funding from the University of Hong Kong unrelated to this work. KKC Man received the CW Maplethorpe Fellowship and personal fees from IQVIA Holdings, Inc. (previously known as QuintilesIMS Holdings, Inc.) unrelated to this work. SP, VWSN, CWS, and WCYL have no conflicts of interests that are directly relevant to the content of this study.
: This study protocol was approved by the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (reference no. UW13-468).